hero-research-news

Research and Publications

Featured Publications

Letter - 65

[White paper] Don't Forget to Look Both Ways: Driving Diversity and Inclusion in Clinical Research

Lowering the barriers to high-quality researchers is core to the mission behind Smart Omix. In the spirit of our launch, our team explores the technological, economic and cultural barriers to entering the field, and how these barriers impacting the diversity of the ecosystem overall.

Download the white paper.

Features-continuous-data

A decentralized, prospective observational study to collect real-world data from patients with myasthenia gravis using smartphones

UCB and Sharecare report results from a 3-month prospective observational study in adults with myasthenia gravis (MG) using fully decentralized methods, to assess the feasibility of real-world data collection from smartphones for patients with this rare disease at MGFA 2022.

Download the poster.

Allergy-study-image

Predicting Environmental Allergies from Real-World Data 

Using Smart Omix, a proprietary digital clinical research platform powering mobile research studies, the Sharecare team developed and trained a machine-learning algorithm to predict the emergence and severity of symptoms related to allergic rhinitis.

Read the paper

 

41746_2021_473_Fig1_HTML

Empowering Clinical Research in a Decentralized World

Our paper in Nature Digital Medicine highlights the implications of new technologies, including edge computing, zero-trust environments, and federating computing in DCTs enabled by digital health technologies can offer improvements in real-time data acquisition remotely while maintaining privacy and security. 

Read the paper

 

Smart Omix for Pharma

Watch the movie, not the trailer

Download our white paper on how pharmaceutical companies can use Smart Omix to easily collect real-world data at scale, streamline processes and gain a richer, more comprehensive picture of an individual's health.

Download the white paper

In the News

Start designing your study for free.

Subscribe to our newsletter.